{
  "docId": "019dd923-5ddf-7308-8fca-67b2c082e364",
  "docSlug": "5c08d15ab76e5ae9",
  "documentTitle": "Trend Compendium 2050 Six megatrends that will shape the world",
  "authorId": "RolandBerger",
  "authorName": "Roland Berger",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 76,
  "pageCount": 86,
  "prevPage": 75,
  "nextPage": 77,
  "slideType": "industry_trends",
  "function": "size_opportunity",
  "density": "dense",
  "nDataPoints": 28,
  "notes": "Includes a sidebar navigation menu for a larger report structure.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bar_chart_stacked",
    "infographic"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ddf-7308-8fca-67b2c082e364/76",
  "deckHref": "/decks/019dd923-5ddf-7308-8fca-67b2c082e364",
  "deckJsonHref": "/decks/019dd923-5ddf-7308-8fca-67b2c082e364.json",
  "deckAnchorHref": "/decks/019dd923-5ddf-7308-8fca-67b2c082e364#slide-76",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Cell and gene therapies are currently the subject of intense research and investment by many pharmaceutical companies.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-e58d-7080-a16a-27f06370873f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.15,
        "y": 0.3
      },
      "kind": "chart",
      "text": "Cell & gene therapy sales, 2020-2026",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e1940a56-660b-4106-9abd-7f4a523263ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.65,
        "y": 0.35
      },
      "kind": "list",
      "text": "Enables treatment of previously incurable diseases; Precision medicine and ability for individualized customization; Long lasting effect, requiring mostly one-off treatments; In the future, possibility of novel curative mechanisms",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f96246a-95b5-47d2-a0ca-91b64e0a72a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "EUR bn: 58.6",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-e58d-7080-a16a-2afa63bfca10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.15,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Cell and gene therapies are currently the subject of intense research and investment by many pharmaceutical companies. The aim is to deliver cures for rare diseases and to enable new therapeutic approaches for more widespread diseases, e.g. oncology or heart failure. Such therapies work by employing engineered cells as therapeutics or by replacing defective or missing genes in a patient's cells",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bdad105a-6ab4-4cf5-837b-26d5eac21453",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.15,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1) Including combination Advanced Therapies and Medicinal Products (ATMPs) Sources: EvaluatePharma; Roland Berger",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76a7ce5b-a767-4ab8-8daa-88f91753719f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.15,
        "y": 0.05
      },
      "kind": "title",
      "text": "Cell and gene therapies exemplify highly promising innovations enabling restoration of biological function and treatment of as yet incurable diseases",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b1212796-feb2-4362-a349-ba1f3c23c463",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "e2ea30b6-d820-4415-b94a-470c363e8152",
      "evidence": "list/bullet: Enables treatment of previously incurable diseases; Precision medicine and ability for individualized customization; Long lasting effect, requiring mostly one-off treatments;",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 86,
      "from": 21,
      "beatId": "a3d8d094-939c-4863-83e3-400ab70554cb",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The document concludes by emphasizing the need for action to address the megatrends.",
      "position": 3,
      "confidence": 0.7,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}